Efficacy of Kan Jang(®) in Patients with Mild COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.
Kan Jang reduced severe cases and virus detection in mild COVID-19 patients. Improved symptoms and reduced inflammatory markers. Effective treatment for mild/moderate cases.
- Ratiani L et al (2023).
- Pharmaceuticals (Basel).
- DOI:
- 10.3390/ph16091196
- PubMed:
- 37765004